False
By Stephanie Vine
June 12, 2025
There has been no new TB vaccine for over 100 years, but a candidate at the Gates Medical Research Institute in phase III has just finished enrolling the target of 20,000 participants.
10 min read
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
By Stephanie Vine
June 2, 2025
Patient fatality reported in clinical trial for investigational gene therapy for Danon disease
2 min read
May 28, 2025
Researchers conduct small phase I study on the potential of placenta-derived stem cell therapy to treat a serious form of MS with limited therapeutic options
2 min read
May 27, 2025
The industry has spent decades optimizing distribution strategies to meet faster timelines. Now, it’s time to think about sustainability.
7 min read
May 12, 2025
Can digital tools help lower the carbon footprint of a clinical trial? First, we need more data.
5 min read
By Stephanie Vine
May 7, 2025
Gene therapy clinical trial shows striking outcomes in children with rare and often fatal immune disorder
2 min read
May 6, 2025
Can making clinical trials more family friendly help increase the number of female participants?
4 min read
By Stephanie Vine
May 1, 2025
Our latest news roundup reports on Amgen’s $900 million investment, EMA’s re-examination of donanemab, philanthropy at Sanofi, and more
3 min read
By Stephanie Vine
April 29, 2025
Non-clinical toxicology study reveals worrying results
1 min read
False